FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.4-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

1208549006: Product containing precisely metformin hydrochloride 850 milligram and sitagliptin (as sitagliptin phosphate) 50 milligram/1 each conventional release oral tablet (clinical drug)


Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Mar 2022. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
4965102012 Product containing precisely metformin hydrochloride 850 milligram and sitagliptin (as sitagliptin phosphate) 50 milligram/1 each conventional release oral tablet (clinical drug) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
4965103019 Metformin hydrochloride 850 mg and sitagliptin (as sitagliptin phosphate) 50 mg oral tablet en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
4965102012 Product containing precisely metformin hydrochloride 850 milligram and sitagliptin (as sitagliptin phosphate) 50 milligram/1 each conventional release oral tablet (clinical drug) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
4965103019 Metformin hydrochloride 850 mg and sitagliptin (as sitagliptin phosphate) 50 mg oral tablet en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Metformin hydrochloride 850 mg and sitagliptin (as sitagliptin phosphate) 50 mg oral tablet Is a Product containing only metformin and sitagliptin in oral dose form (medicinal product form) true Inferred relationship Existential restriction modifier (core metadata concept)
Metformin hydrochloride 850 mg and sitagliptin (as sitagliptin phosphate) 50 mg oral tablet Has manufactured dose form Conventional release oral tablet (dose form) true Inferred relationship Existential restriction modifier (core metadata concept)
Metformin hydrochloride 850 mg and sitagliptin (as sitagliptin phosphate) 50 mg oral tablet Has unit of presentation Tablet (unit of presentation) true Inferred relationship Existential restriction modifier (core metadata concept)
Metformin hydrochloride 850 mg and sitagliptin (as sitagliptin phosphate) 50 mg oral tablet Has precise active ingredient Metformin hydrochloride true Inferred relationship Existential restriction modifier (core metadata concept) 1
Metformin hydrochloride 850 mg and sitagliptin (as sitagliptin phosphate) 50 mg oral tablet Has basis of strength substance (attribute) Metformin hydrochloride true Inferred relationship Existential restriction modifier (core metadata concept) 1
Metformin hydrochloride 850 mg and sitagliptin (as sitagliptin phosphate) 50 mg oral tablet Has presentation strength numerator unit (attribute) mg true Inferred relationship Existential restriction modifier (core metadata concept) 1
Metformin hydrochloride 850 mg and sitagliptin (as sitagliptin phosphate) 50 mg oral tablet Has presentation strength denominator unit (attribute) Tablet (unit of presentation) true Inferred relationship Existential restriction modifier (core metadata concept) 1
Metformin hydrochloride 850 mg and sitagliptin (as sitagliptin phosphate) 50 mg oral tablet Has precise active ingredient Sitagliptin phosphate (substance) true Inferred relationship Existential restriction modifier (core metadata concept) 2
Metformin hydrochloride 850 mg and sitagliptin (as sitagliptin phosphate) 50 mg oral tablet Has basis of strength substance (attribute) Sitagliptin (substance) true Inferred relationship Existential restriction modifier (core metadata concept) 2
Metformin hydrochloride 850 mg and sitagliptin (as sitagliptin phosphate) 50 mg oral tablet Has presentation strength numerator unit (attribute) mg true Inferred relationship Existential restriction modifier (core metadata concept) 2
Metformin hydrochloride 850 mg and sitagliptin (as sitagliptin phosphate) 50 mg oral tablet Has presentation strength denominator unit (attribute) Tablet (unit of presentation) true Inferred relationship Existential restriction modifier (core metadata concept) 2

Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start